Thursday, September 17, 2026RSS
Peptide.Wire

The daily wire on therapeutic peptides. Regulatory, research, compounding and the incretin race, condensed.

Marketsnovo-nordiskobesityglp-1pipeline

Novo Nordisk trims pipeline and rebrands amid obesity competition

The Danish drugmaker narrows development priorities as rivals press in weight-loss care.

TR
By Tom Reyes · Markets Editor
Sep 17 04:50 ETSource: ad-hoc-news.de

The wire

  1. 01Novo Nordisk cut pipeline programs and launched a rebranding as obesity competition intensifies.
  2. 02Reflects pressure on the GLP-1 leader from rival weight-loss entrants.
  3. 03Which programs were dropped and financial impact were not specified.

From the source

Novo Nordisk Trims Pipeline and Rebrands as Competition in Obesity Care Intensifies

Read at news.google.com